Arjo Ab Class B · OMXSTO:ARJO_B

Arjo Ab Class B — Q4 2024 Earnings Presentation

20 slides from Arjo Ab Class B's earnings presentation, Jan 30, 2025

  1. Slide 1: Arjo Q4 Report 2024

    ARJO Q4 REPORT 2024 January 30, 2025 Niclas Sjöswärd, Interim CEO Christofer Carlsson, Interim CFO 1

  2. Slide 2: Agenda

    Business update – Q4 & FY 2024 Financials in detail Agenda Outlook 2025 Key takeaways Q&A

  3. Slide 3: A solid finish to the year

    A solid finish to the year Growth across regions • Healthy demand for Service and Rental globally Net sales Gross • Continued growth in US and Canada organic growth margin • Lower demand for capital equipment in Europe, i.e. France • UK improving with confirmed NHS budgets 3.1% 44.7% Profitability i

  4. Slide 4: Solid performance despite somewhat unpredictable environment

    Solid performance despite somewhat unpredictable environment • Strong service and rental development globally, Net sales Gross margin organic growth with further potential • Continued growth in the US and Canada, yet weaker 3.1% 43.5% demand for capital equipment in Western Europe in H2 • Improved p

  5. Slide 5: North America

    North America Continued growth in the US Q4 org. net sales • Continued healthy demand within Rental and Service • Increasing Patient Handling sales +7.8% • Lower DVT volumes as forecasted FY org. net sales Another quarter of profitable growth in Canada • Service, Rental and Capital all perform well

  6. Slide 6: Global Sales – Western Europe

    Global Sales Western European markets (+1.9% in Q4; +1.3% FY) Q4 org. net sales • Healthy demand in the UK following NHS budget confirmation, +0.3% +10% growth in Q4 • Weaker demand for capital equipment remains in some European markets, i.e. France – low visibility remains FY org. net sales • Posit

  7. Slide 7: Global Sales – Rest of the World

    Global Sales Rest of the World markets (-3.7% in Q4; +4.1% FY) Q4 org. net sales • Somewhat weaker quarter in for example China +0.3 • Healthy demand in Africa, India, Hong Kong and UAE • Investments to drive growth in Japan starting to show positive signs FY org. net sales • Signs of EU funding sta

  8. Slide 8: Somewhat lower gross margin in Q4 but solid improvement activities in place

    Somewhat lower gross margin in Q4 but solid improvement Gross profit bridge – Q4 2024 vs. Q4 2023 (MSEK) activities in place Margin development x Margin (Percent) x (Percentage point) • Q4 margin expansion held back by lower capital equipment volumes in the quarter 45.3% N/A -0.3 p.p. -0.2 p.p. 44.7

  9. Slide 9: Solid initiatives for year over year gross margin improvement

    Solid initiatives for year over year gross margin improvement

  10. Slide 10: High activity level and solid cost control

    High activity level and solid cost control Adj. EBIT bridge – Q4 2024 vs. Q4 2023 (MSEK) x Margin (Percent) • Adj. EBIT improvement vs. Q4 2023 11.9% 12.5% • Positive FX effects -34 -3 • Continued good cost control across 28 42 the value chain 342 375 Q4 2023 Gross profit OPEX Other Translation Q4 2

  11. Slide 11: Driving value by leveraging OPEX

    Driving value by leveraging OPEX

  12. Slide 12: Q4 working capital and operating cash flow

    Q4 working capital and operating cash flow Working capital days increasing slightly Operating cash flow improved sequentially during the year Working capital days – Q1.22-Q4.24 Operating cash flow – Q1.22-Q4.24 Operating cash flow (MSEK)* Working capital days* 734 565 99 95 96 96 95 512 91 479 86 42

  13. Slide 13: Q4 net debt and leverage

    Q4 net debt and leverage Net debt decreasing during Q4 Improvement in leverage Net debt – Q1.22-Q4.24 Leverage – Q1.22-Q4.24 Net debt, incl. IFRS16 (BSEK) Net debt / Adj EBITDA, multiple (R12)* 5.3 5.1 5.1 5.2 5.0 2.8 2.8 2.8 4.7 2.7 2.6 2.6 4.6 2.4 4.5 2.3 2.3 2.3 4.3 4.4 4.4 2.2 4.2 2.0 Q1.22 Q2.2

  14. Slide 14: Global launch of Symbliss – the next-generation integrated bathing system

    Global launch of Symbliss – the next-generation integrated bathing system • Enables safe and efficient hygiene routines across all mobility levels • Highest rating from the Dementia Services Development Centre (DSDC) • Strengthens Arjo’s Long-Term Care market positions • Attractive aftermarket and s

  15. Slide 15: Outlook 2025

    Outlook 2025 Organic net sales growth for 2025 is expected to be within the Group’s target interval of 3-5%

  16. Slide 16: Key takeaways

    Key takeaways • A solid finish to the year • Healthy demand for Service and Rental globally • Continued growth in US and Canada, and positive development in the UK • Improved profitability and solid initiatives to improve further moving forward • Strong financial position with further improved lever

  17. Slide 17: Q&A

    Q&A ai2°

  18. Slide 18: Financial calendar and further questions

    Financial calendar Capital Markets Update POSTPONED Annual and Sustainability Report 2024 April 2025 Interim Report Jan-Mar 2025 April 29, 2025 Annual General Meeting 2025 April 29, 2025 Interim Report Jan-Jun 2025 July 11, 2025 Interim Report Jan-Sep 2025 October 22, 2025 Further questions Maria Ni

  19. Slide 19: Forward looking information

    Forward looking information This document contains forward-looking information based on the current expectations of Arjo’s management. Although management deems that the expectations presented by such forward-looking information are reasonable, no guarantee can be given that these expectations will

  20. Slide 20: Empowering Movement

    aifJjJoO EMPOWERING MOVEMENT

Arjo — Q4 2024 Earnings Presentation on 6ix